Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
University Hospital Erlangen, Erlangen (Germany)
9 More presentations in this session
Doctor H. Takase (Hamamatsu, JP)
Doctor T. Hamaoka (Kanazawa, JP)
Associate Professor J. Vaclavik (Ostrava, CZ)
Doctor D. Vukadinovic (Homburg, DE)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
You may be interested in
Congress Presentation
